UW Medicine clinical scientists will help evaluate therapies for long COVID as part of the RECOVER Initiative clinical trials series directed by the National Institutes of Health.
RECOVER, which stands for Researching COVID to Enhance Recovery, encompasses several studies nationwide to assess several potential therapies. These include drugs, biologics, medical devices and other approaches.
The Seattle site is enrolling potential participants for one such trial, RECOVER-NEURO. It will examine interventions for brain fog, memory lapses, difficulty with attention and other cognitive problems that persistently trouble some people who have had COVID.
RECOVER, which stands for Researching COVID to Enhance Recovery, encompasses several studies nationwide to assess several potential therapies. These include drugs, biologics, medical devices and other approaches.
The Seattle site is enrolling potential participants for one such trial, RECOVER-NEURO. It will examine interventions for brain fog, memory lapses, difficulty with attention and other cognitive problems that persistently trouble some people who have had COVID.
If you are interested to enroll in RECOVER-NEURO, please email uwrecoverstudy@uw.edu.
More details here
More details here
No comments:
Post a Comment
We encourage the thoughtful sharing of information and ideas. We expect comments to be civil and respectful, with no personal attacks or offensive language. We reserve the right to delete any comment.